IDEXX Laboratories Inc
IDXX: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$658.00 | Tbdbw | Qcjhzcckpm |
Idexx's Upcoming New InVue Platform Launch Should Support Growth Into the Long Term
Business Strategy and Outlook
Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership continues to grow, offering a secular tailwind since the late 1980s. Moreover, pet owners have demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994.